Pharmacokinetics Parameters of Ferulic Acid Methylester Nitric Oxide Donor in Mice
1. College of Pharmacy and Chemistry, Dali University, Dali,Yunnan 671000, China;2. College of Chemical and Chemistry Engineering, Hunan University, Changsha 410082, China
LIU Ying-Lin, LI Yan-Lai, LIU Hao-Ran, MA Li-Xue. Pharmacokinetics Parameters of Ferulic Acid Methylester Nitric Oxide Donor in Mice[J]. J4, 2013, 12(9): 17-20.
〔1〕王焕,付平,谢席胜,等. 阿魏酸哌嗪对糖尿病大鼠肾脏
的保护作用〔J〕.中国中西医结合肾病杂志,2008,9(7):
582-585.
〔2〕Fujita A,Sasaki H,Doi A,et al. Ferulic acid prevents
pathological and functional abnormalities of the kidney
in Otsuka Long-Evans Tokushima Fatty diabetic rats.
〔J〕.Diabetes research and clinical practice,2008,79
(1):11-17.
〔3〕Bonomini M,Sirolli V,Di Pietro N,et al. Reduced nitric
oxide bioavailability in chronic renal failure:a new factor
of progression〔J〕. Giornale italiano di nefrologia,2008,
25(3):306-316.
〔4〕Vaziri ND. Effect of chronic renal failure on nitric oxide
metabolism〔J〕. American Journal of Kidney Diseases,
2001,38(S1):S74-S79.
〔5〕Tessari P,Cecchet D,Cosma A,et al. Nitric oxide
synthesis is reduced in subjects with Type 2 Diabetes and
nephropathy〔J〕. Diabetes,2010,59(9):2152-2159.
〔6〕刘浩然,李燕来,张会杰,等.一种新型阿魏酸NO供体的
合成〔J〕.湖南师范大学学报:医学版,2011,8(2):92-94.
〔7〕黄秀旺,许建华,陈元仲.雷公藤内酯醇在大鼠体内的组
织分布〔J〕.中国临床药理学与治疗学,2008,13(7):764-
767.
〔8〕张勇,周建平,霍美蓉.基于Excel的药动学数据分析程
序:PKSlover1.0的编写和验证〔j〕.数理医药学杂志,2007,
20(1):58-61.
〔9〕Zhang Y,Huo M,Zhou J,et al. PKSolver:An addin
program for pharmacokinetic and pharmacodynamic data
analysis in Microsoft Excel〔J〕. Computer Methods and
Programs in Biomedicine,2010,99(3):306-314.
〔10〕刘晓峰,武新安,魏玉辉,等. 阿魏酸和川芎汤剂中阿魏
酸在大鼠体内的吸收动力学研究〔J〕.中药材,2007,30
(7):831-833.
〔11〕宋洪涛,郭涛,张跃新,等. 阿魏酸在大鼠体内肠吸收动
力学的研究〔J〕.中草药,2005,36(10):1514-1517.
〔12〕李晓蓉,李晓莉,王丽娟,等.丹参水溶性主成分丹参素
和阿魏酸合用的药动学相互作用〔J〕.中国药理学通报,
2007,23(7):968-972.